Charming Medical Ltd. Class AMCTA
13F holders, Q1 2026 (March 31)3holders
0new positions
0sold out
$25.22avg. 13F price*
At the end of Q1 2026, 3 institutions reported holding Charming Medical Ltd. Class A (MCTA) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were UBS Group AG ($732K), Geode Capital Management, LLC ($316K) and JFS Wealth Advisors, LLC ($0).
- Company
- Charming Medical Ltd. Class A
- CUSIP
- G20528108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 3,300 shares sold, net −3,300 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| UBS Group AG | 0.00% | Reduce -11.7% | 24,949 | $732K |
| Geode Capital Management, LLC | 0.00% | No change | 10,752 | $316K |
| JFS Wealth Advisors, LLC | 0.00% | No change | 5,850 | $0 |
"% of holder's portfolio" is MCTA's weight in each manager's 13F, not the share of Charming Medical Ltd. Class A the manager owns.